Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Spanish reimbursement system

- PMLiVE

UK government ‘concerned’ over Elliott Management’s plans for GSK

'Activist' hedge fund Elliott Management has built up a sizeable stake in the British drugmaker

- PMLiVE

Origins Insights nominated for two EVCOM Clarion Awards

Origins Insights excited to have our 'What One Thing...?' RDD film shortlisted for two awards!

Origins – The Patient Focused Specialists

- PMLiVE

The lessons learned from COVID-19’s impact on oncology trials

How COVID-19’s lasting legacy will reshape clinical cancer research

- PMLiVE

EMA concludes GSK, Vir’s mAb can be used to treat high-risk COVID-19 patients

Recommendations can be used to support national advice prior to marketing authorisation

- PMLiVE

AZ, Pfizer/BioNTech COVID-19 vaccines ‘highly effective’ against Indian variant

UK study finds vaccines are likely to be effective in preventing hospitalisation/death

- PMLiVE

Pfizer to evaluate its pneumococcal vaccine alongside COVID-19 booster jab

Trial will enrol 600 adults, aged 65 and older, from the phase 3 Pfizer/BioNTech COVID-19 vaccine trial

- PMLiVE

The Lucid Group Guide

We work hard at Lucid Group. Transforming lives, it's not a walk in the park. We’re a team. In fact, we are many teams. Working together to discover, define, design,...

Lucid Group Communications Limited

Our #LucidLife

We asked our people: Why do you do what you do? - What makes you get out of bed in the morning? The responses had a common theme - it's...

Lucid Group Communications Limited

- PMLiVE

Annovis Bio’s lead therapeutic shows ‘significant improvements’ in Alzheimer’s, Parkinson’s

Patients from a small phase 2a study saw their ADAS-Cog11 scores improve by 4.4 points

Happiness and wellbeing: you can have both, but they’re not the same thing

"Wellbeing needs to remain central to leadersip", writes Paul Hutchings, founder of fox&cat. In this article Paul and his network explain the difference between wellbeing and happiness. And how problems...

Fox&Cat

- PMLiVE

Market shaping for better healthcare decisions

By Tim Warren

- PMLiVE

bluebird bio’s CALD gene therapy Skysona gains positive opinion from CHMP

CHMP's marketing authorisation recommendation is a step towards gaining EU approval

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links